A new therapeutic approach made possible by genetic engineering
We have developed the first and only platform to genetically engineer small molecule therapeutics from fungi and plants — and discover new compounds
Addressing a major gap in treatment
Our team is developing new therapies to address the continuing unmet need of treating neuropsychiatric and neurological disorders.
With our technology, we can potentiate neuroactive compounds produced by plants and fungi to treat patients who are affected by devastating diseases such as depression, post-traumatic stress disorder, substance abuse disorders, and pain.